Manhattan US Attorney Preet Bharara has asked the Securities and Exchange Commission to hold off on its decision about former hedge-fund kingpin Steve Cohen for three more months...
Keep Reading →
August 27 - Hedge Funds
When William Ackman took the stage at the AXA Equitable Auditorium in Midtown Manhattan on April 22, investors were still digesting the news that his firm, Pershing Square Capital...
Keep Reading →
August 22 - Hedge Funds
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Bill Ackman’s Pershing Square Capital Management will today comply with one of Allergan, Inc.
Keep Reading →
August 22 - Hedge Funds, News
Having lost all his savings on Black Monday in 1987, James Dinan made a remarkable comeback, setting up his hedge fund, York Capital Management, in 1991 with $3.6 million and...
Keep Reading →
August 22 - Hedge Funds, News
Stephen Mandel’s Lone Pine Capital has revealed for the second quarter a portfolio of 67 companies worth $24.7 billion.
Keep Reading →
August 20 - Hedge Funds, News
In its latest 13F filing with the U.S.
Keep Reading →
August 18 - Hedge Funds, News
Allergan, Inc. (NYSE:AGN)'s stock saw a massive upside in April when it was revealed that Valeant Pharmaceuticals Intl Inc (NYSE:VRX) was trying to buy the company with the...
Keep Reading →
August 15 - Hedge Funds, News
Jeffrey Ubben’s ValueAct Capital has disclosed its holdings for the second quarter, revealing 16 investments which have a current market value of $13.5 billion.
Keep Reading →
August 15 - Hedge Funds, News
Speaking to CNBC’s Scott Wapner over the phone yesterday, investor and hedge fund manager Bill Ackman denied the allegations set forth against him and Valeant Pharmaceuticals...
Keep Reading →
August 15 - Hedge Funds, News
The hedge fund billionaire Louis M.
Keep Reading →
August 14 - Hedge Funds
As the 13F season continues, let’s take a look at Giovine Capital’s recently disclosed long equity positions for the second quarter of 2014.
Keep Reading →
August 12 - Hedge Funds, News
Carl Icahn makes more money between sips on his outsized Martinis than most mortals make in a lifetime.
Keep Reading →
August 4 - Hedge Funds
Six Flags Entertainment Corp (NYSE:SIX), the world’s largest regional theme park company, reported second quarter revenues of $376.55 million, up from last year’s second...
Keep Reading →
July 22 - Earnings Report, News
Investors have pulled more than $1 billion from Eric Mindich's Eton Park Fund, managed by his New York-based multistrategy hedge fund firm Eton Park Capital Management, since ...
Keep Reading →
July 18 - Hedge Funds
The Fed is out of step with Wall Street, say some of the country’s wealthiest investors.
Keep Reading →
July 16 - Hedge Funds
Zug, Switzerland-based Argentiere Capital is an alternative investment management firm, which was founded by Deepak Gulati. Mr.
Keep Reading →
July 16 - Hedge Funds, News
In "Squawk on the Street" on CNBC, the co-anchor of the show Jim Cramer, comments on the Q2 earnings of Johnson & Johnson (NYSE:JNJ), which beats analysts expectations, and the...
Keep Reading →
July 15 - News
Long Island hedge-fund investor James Simons and his wife have given $50 million to the Cold Spring Harbor Laboratory to establish a center that uses quantitative tools to understand...
Keep Reading →
July 7 - Hedge Funds
While most hedge funds continue to lag the market, having returned an average of only 2% through May, about half of what S&P 500 (INDEXSP:.INX) returned, a few of them have managed...
Keep Reading →
July 7 - Hedge Funds, News
Pershing Square, managed by Bill Ackman, revealed in a new filing with the U.S. Securities and Exchange Commission that it has settled a lawsuit with Allergan Inc. (NYSE:AGN).
Keep Reading →
July 1 - Hedge Funds, News
North Tide Capital financial investment advisory firm headquartered in Boston, Massachusetts, founded and managed by Conan Laughlin. Before this, Mr.
Keep Reading →
June 4 - Hedge Funds, News
Third Point LLC, a hedge fund controlled by activist investor Daniel Loeb, has bought more than 1 million shares of the common stock of Roper Industries, Inc. (NYSE:ROP).
Keep Reading →
May 27 - Hedge Funds
The asset management industry is playing US regulators against their international counterparts and stirring national sentiment on Capitol Hill in an attempt to head off new regulation...
Keep Reading →
May 19 - Hedge Funds
Short-seller James Chanos said he’s betting against shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) -2.92% amid its unsolicited $46 billion bid for Allergan, Inc.
Keep Reading →
May 15 - Hedge Funds
Canada’s largest pharmaceutical company and the U.S. activist investor who overhauled CP Rail have joined forces in a mega-deal to buy Allergan, Inc.
Keep Reading →
April 22 - Hedge Funds
Bill Ackman's Pershing Square has added Allergan, Inc. (NYSE:AGN) to its equity portfolio.
Keep Reading →
April 22 - Hedge Funds, News
Ghost Tree Capital is a healthcare-oriented hedge fund headquartered in New York.
Keep Reading →
February 27 - Hedge Funds, News
Nehal Chopra is a graduate from the Wharton School of the University of Pennsylvania.
Keep Reading →
February 24 - Hedge Funds, News
This space has a bright future outlook, and according to Markets and Markets, it is projected to reach a market size of $36 billion by 2014, increasing at a CAGR of 5.4% during...
Keep Reading →
September 11 - News
In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to track Mr. Market.
Keep Reading →
September 5 - News
Allergan, Inc. (NYSE:AGN), the diversified health care giant best known for Botox, boasts an impressive portfolio of products.
Keep Reading →
August 30 - News
In the eyes of many of your fellow readers, hedge funds are seen as useless, old financial vehicles of an era lost to time.
Keep Reading →
August 26 - News
If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost to time.
Keep Reading →
August 25 - News
Like most pharma companies, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)'s stock price generally trades akin to the actions of a roller coaster.
Keep Reading →
August 22 - News
The National Headache Foundation (yes, there is such an organization) says that around 30 million Americans suffer from migraines.
Keep Reading →
August 6 - News
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will release its quarterly report on Tuesday, and the company's stock has been on an absolute tear over the past year.
Keep Reading →
August 2 - News
By age 35, around two-thirds of all American men will have begun to experience androgenetic alopecia, more commonly known as male pattern baldness.
Keep Reading →
July 24 - News
One-fourth of all migraine patients suffer nasty side effects from the market's dominant migraine-fighting treatments.
Keep Reading →
July 9 - News
For the last five years, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) CEO Rajesh Shrotriya has always insisted that Spectrum Pharmaceuticals, Inc.
Keep Reading →
July 8 - News
After a strong bull run in 2013, it appears that the markets are set to reverse and enter bear territory.
Keep Reading →
July 5 - News
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Keep Reading →
July 3 - News
On June 24, the Food and Drug Administration issued “bioequivalence recommendations” for 15 active ingredients used in prescription medications.
Keep Reading →
June 28 - News
Johnson & Johnson (NYSE:JNJ) stands alone as a leader across the major health-care industries.
Keep Reading →
June 27 - News
Last week, Wall Street couldn't think about anything other than the specter of Fed tapering. This week, it's found a new central bank to disapprove of.
Keep Reading →
June 25 - News
Botox may be best known for its ability to combat crow's feet and other facial wrinkles, but it also serves an important role in the medical community.
Keep Reading →
June 19 - News
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’ 1,100% gain makes it one of the best performing stocks in the market.
Keep Reading →
June 12 - News
One of the best ways that retail investors can try to decide which stocks will make for a promising investment is to look at what the hedge funds are doing.
Keep Reading →
June 10 - Hedge Funds
Summer doesn't officially arrive for a few more weeks, but the first week of June packed some real heat.
Keep Reading →
June 10 - News
In the end, numbers are just numbers and while they are an indispensable part of an investor's self-assessment, they do not always reveal the full details.
Keep Reading →
June 10 - News
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had a busy couple of months.
Keep Reading →
June 3 - News